Año: 2010
Journal Impact Factor (JIF): 1.150
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| BIOLOGY | SCIE | 49/86 | Q3 | T2 | D6 |
| MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | 77/106 | Q3 | T3 | D8 |
Año: 2017
Journal Citation Indicator (JCI): 0,510
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOLOGY | 54/98 | Q3 | T2 | D6 | 45,41 |
| MEDICINE, RESEARCH & EXPERIMENTAL | 120/185 | Q3 | T2 | D7 | 35,41 |
Año:
2011
CiteScore:
2,100
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| General Pharmacology, Toxicology and Pharmaceutics | 14/62 | Q1 | T1 | D3 |
| General Medicine | 1625/3161 | Q3 | T2 | D6 |
| Biochemistry | 230/354 | Q3 | T2 | D7 |
| Biophysics | 71/114 | Q3 | T2 | D7 |
| General Neuroscience | 62/97 | Q3 | T2 | D7 |
| Immunology | 122/170 | Q3 | T3 | D8 |
| Physiology | 116/161 | Q3 | T3 | D8 |
| Cell Biology | 188/243 | Q4 | T3 | D8 |
SJR año:
2010
Factor de Impacto:
0,476
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 12/94 | Q1 | T1 | D2 |
| Medicine (miscellaneous) | 1125/2840 | Q2 | T2 | D4 |
| Biochemistry | 232/391 | Q3 | T2 | D6 |
| Biophysics | 75/125 | Q3 | T2 | D6 |
| Neuroscience (miscellaneous) | 84/141 | Q3 | T2 | D6 |
| Immunology | 123/197 | Q3 | T2 | D7 |
| Physiology | 129/183 | Q3 | T3 | D8 |
| Cell Biology | 191/260 | Q4 | T3 | D8 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Herrero, C. | Hospital Clínico Universitario de Salamanca (Spain) |
| 2 | Hospital Clínico Universitario de Salamanca (Spain) |